China Resources Pharmaceutical Group Ltd
03320
Company Profile
Business description
China Resources Pharmaceutical is the third-largest medical distributor in China by revenue. It is an integrated pharmaceutical company specializing in research and development, manufacturing, medical distribution, and retail pharmacies. As of 2024, the medical distribution business accounts for 82.8% of its total revenue. CR Pharma’s manufacturing business, 18.0% of total revenue, has subsidiaries with a strong presence in traditional Chinese medicine and consumer healthcare.
Contact
26 Harbour Road
Room 4104-05, 41st Floor, China Resources Building
Wanchai
HKGT: +852 25938991
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2025
Employees
86,000
Stocks News & Analysis
stocks
ChatGPT enters the retail space and one company surges
Investors cheer the ability to purchase directly from ChatGPT.
stocks
Alibaba fair value increases by 49%
Stronger-than-expected AI demand internationally and domestically.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 9,135.90 | 19.50 | -0.21% |
CAC 40 | 7,862.46 | 18.41 | -0.23% |
DAX 40 | 23,791.29 | 46.23 | 0.19% |
Dow JONES (US) | 46,316.07 | 68.78 | 0.15% |
FTSE 100 | 9,317.09 | 17.25 | 0.19% |
HKSE | 26,855.56 | 232.68 | 0.87% |
NASDAQ | 22,591.15 | 107.09 | 0.48% |
Nikkei 225 | 44,932.63 | 111.12 | -0.25% |
NZX 50 Index | 13,292.36 | 159.80 | 1.22% |
S&P 500 | 6,661.21 | 0.00 | 0.00% |
S&P/ASX 200 | 8,848.80 | 20.50 | -0.23% |
SSE Composite Index | 3,882.78 | 20.25 | 0.52% |